0001178913-23-003157.txt : 20230914
0001178913-23-003157.hdr.sgml : 20230914
20230914170338
ACCESSION NUMBER: 0001178913-23-003157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230913
FILED AS OF DATE: 20230914
DATE AS OF CHANGE: 20230914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taitel Haya
CENTRAL INDEX KEY: 0001979599
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38556
FILM NUMBER: 231255743
MAIL ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: 5TH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entera Bio Ltd.
CENTRAL INDEX KEY: 0001638097
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
BUSINESS PHONE: 972-2-532-7151
MAIL ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
4
1
zk2330300.xml
X0508
4
2023-09-13
0
0001638097
Entera Bio Ltd.
ENTX
0001979599
Taitel Haya
KIRYAT HADASSAH, MINRAV BUILDING,
5TH FLOOR
JERUSALEM
L3
9112002
ISRAEL
1
0
0
0
0
Stock Option (right to buy)
0.809
2023-09-13
4
A
0
33368
0
A
2033-06-06
Ordinary Shares, par value NIS 0.0000769 per share
33368
33368
D
This grant of options was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on June 6, 2023, subject to approval by the Company's shareholders, which was obtained on September 13, 2023. The options vest ratably on an annual basis over a three-year period that commenced on June 6, 2023.
/s/ Dana Yaacov-Garbeli, Attorney-in-Fact
2023-09-14